Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-09

DFTX vs SNYRQ: stock comparison and AI forecast

Definium Therapeutics, Inc. (DFTX) and Synergy Chc Corp. (SNYRQ) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Medicinal Chemicals & Botanical Products

DFTX Definium Therapeutics, Inc.

Market Cap
$4.47B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
OTC · Medicinal Chemicals & Botanical Products

SNYRQ Synergy Chc Corp.

Market Cap
n/a
P/E Ratio
–
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

DFTX · SNYRQ

Key facts

  • Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricDFTXSNYRQ
Market Cap$4.47B–
P/B Ratio4.87x–
EPS$-3.00$-0.22
Book Value/Share$6.84–

Profitability & Margins

MetricDFTXSNYRQ
ROE-38.5%–
ROA-31.8%-13.1%
ROIC-23.8%–
Gross Margin–74.4%
Operating Margin–14.4%
Net Margin–-2.9%
EBT Margin–0.2%
Tax Rate–257.4%

Financial Health

MetricDFTXSNYRQ
Current Ratio6.95x0.93x
Quick Ratio–0.43x
D/E Ratio0.21x–
Financial Leverage1.21x–
Interest Coverage-60.9x–
Working Capital$935M-$500K

Cash Flow

MetricDFTXSNYRQ
Operating Cash Flow-$168M-$5M

Operational Efficiency

MetricDFTXSNYRQ
Inventory Turnover–2.3x
Days Inventory–159 days
Payables Period–9 days

Income Statement

MetricDFTXSNYRQ
Operating Income-$228M$4M
Net Income-$354M-$850K
R&D Expense$155M–
SG&A Expense–$18M
Cost of Goods Sold–$8M

Dividend & Shareholder Information

MetricDFTXSNYRQ
Shares Outstanding134M–
Net Income Growth–-125.9%
FAQ

DFTX vs SNYRQ: stock comparison and AI forecast

Which one does Intratio's AI model rank higher, DFTX or SNYRQ?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.